Conference

ESMO 2018 Congress

Meet with Q2 Solutions at ESMO Conference 2018 (IQVIA's booth #275)and learn how our closely tailored solutions can help you harness the latest wave of progress against cancer

Munich, Germany | October 19, 2018 - October 23, 2018 | 08:00 - 17:00 Add to Calendar
Schedule a Meeting

About This Event

Q2 Solutions is dedicated to powering your oncology study by leveraging latest industry developments spanning from precision medicine, biomarkers, companion diagnostics, esoteric testing, high quality data, bioinformatics and analytics, to robust logistics and sample management.

Our Oncology Center of Excellence and biomarker discovery experts can help you gain invaluable insights and a better understanding of therapeutic targets, molecular signaling, drug biology and patient response. Q2 Solutions has developed dramatically more efficient means of enrolling rare, biomarker defined patients and can partner with you in optimizing your strategy for patient selection.

Our range of genomic services and dedicated team work with you to optimize cancer treatment decisions and ensure that the right drug is used to treat the right patient at the right time. Employing a comprehensive suite of genomic, molecular and protein-based platforms we can rapidly and seamlessly develop, test, transfer, and integrate biological markers to accelerate your oncology program.

Schedule a meeting with Q2 Solutions at this year’s ESMO Conference to learn how through our deep scientific expertise, industry-leading technology and precision medicine capabilities, we can help you bring continuous improvements in oncology patient care.

We look forward to meeting you in Munich.


Related Services:
Q2 Solutions Central Laboratory Services

Optimized logistics, deeper science, better insights

Companion Diagnostic Expertise

Learn how we can ensure success in your next companion diagnostic development program

Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options

Q2 Solutions Biomarker Services

Providing tools and experience to maximize your biomarker strategy

Genomic Based Solutions for Your Immuno-oncology Drug Development Needs

Genomics-based biomarker approach

Q2 Solutions Comprehensive Cancer Panel

Targeted sequencing assay

Read More